US Patent Issued to Genentech on Oct. 14 for "Pharmaceutical compositions comprising AKT protein kinase inhibitors" (Swiss, American Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,492, issued on Oct. 14, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Pharmaceutical compositions comprising AKT protein kinase inhibitors" was invented by Reinhard Reents (Basel, Switzerland), Pirmin Hidber (Basel, Switzerland), Andre Hell (Basel, Switzerland), Peter Steidle (Basel, Switzerland), Martin Wunderlich (Basel, Switzerland), Marie Pepelnjak (Basel, Switzerland), Francis Gosselin (South San Francisco, Calif.) and Edward Yost (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pharmaceutical compositions comprising Akt protein kinase inhibitors with therapeutic activ...